Tissue Engineering And Nanotheranostics

(Steven Felgate) #1

“9.61x6.69” b2815 Tissue Engineering and Nanotheranostics


Multifunctional Nanomaterials for Cancer Theranostics 239

is also achievable by utilization of CNTs’ unique optical properties.^186


When conjugated with a targeting ligand, CNTs can be adopted as


tumor­selective delivery vectors. Functionalized MWCNTs modified


with a ligand of LRP receptor of angiopep­2 (ANG) were used for the


targeted delivery of DOX to glioma. Improved therapeutic efficacy


was obtained for DOX–MWCNTs–PEG–ANG when compared with


free DOX.^185 Covalent binding of drugs onto CNTs can also be


employed for hydrophilic drugs. For example, the anticancer drug of


cisplatin and targeting ligand of epidermal growth factor (EGF) were


covalently attached to SWCNTs and had enhanced killing efficacy of


cancer cells.187,188 According to the literatures reported, CNTs can


also be good gene delivery vector of plasmid DNA and small interfer­


ing RNA (siRNA).189–192 Other categories of carbon nanomaterials are


nanosized graphene including graphene oxide (GO), reduced gra­


phene oxide (RGO), and hybrid graphene nanostructures. With


unique physical and chemical characteristics of ultra­high surface area,


optical absorption, and versatile surface modification, graphene also


attracts enormous research interests.63,193–198 Like CNTs, the presence


of reactive functional groups and localized π­electrons, which support


the π–π bond with aromatic compounds such as DOX, render gra­


phene a suitable candidate as a drug delivery system.195,199 Moreover,


the multifunctional graphene theranostics has also been developed.


For example, DOX was loaded onto magnetic GO to be used for


MRI detectable and magnetically targeted drug delivery.^2 00–202


Following a similar approach, a GO­based T 1 MRI detectable nano­


platform was developed via a GO­gadolinium complex.203,204 Graphene


derivatives have also been used for directing a gene of DNA or RNA,


with PEI or chitosan being two primary mediators to improve the


DNA/RNA binding and condensation, to the cancerous sites.205–211


3. Nanotherapeutic Agents


3.1. Anti-cancer Drugs


Up to now, DOX and paclitaxel (PTX) have been two of the most


extensively studied cancer therapeutics that have been encapsulated


into nanoparticles for theranostic applications.^73 PEGylated liposomal

Free download pdf